Gilead sciences international, ltd.

ADHARA, Asociacion VIH/sida Grant funding to support ADHARA’s activities in European Testing Week 2017, comprising of promotion of rapid testing and increasing the knowledge of HIV and Hep C by an awareness campaign and educational and communication activities. € 10,011.10 Africa Advocacy Foundation Grant funding to support the M-Care Training Programme which aims to equip 20 European migrant community advocates with specific skills and resources to mobilise, educate and empower their communities to fully participate in, and influence the planning and delivering healthcare services, particularly the prevention, testing, treatment access and adherence of HIV, viral hepatitis and tuberculosis. € 60,000.00 AGIHAS Fees and related expenses for provision of consultancy services as part of the “Meeting of Minds” project. £ 1,397.82 AIDS Fondet Fees and related expenses for provision of consultancy services as a member of the steering committee for the MSM campaign. £ 1,696.90 ARDHIS Fees and related expenses for provision of consultancy services as a member of the steering committee for the MSM campaign. £ 1,342.40 Asociación Apoyo positive Fees and related expenses for provision of consultancy services as a member of the steering committee for the MSM campaign. £ 1,513.05 Associação Abraço Fees and related expenses for provision of consultancy services as a member of the steering committee for the MSM campaign. £ 1,310.31 Australian IDU Grant funding to support a project to develop and deliver an hepatitis C education program targeting people who inject drugs seeking hepatitis C treatment. € 29,083.00 BASELINE Fees for provision of consultancy services at multidisciplinary advisory board. £ 900.00 BASELINE Expenses related to provision of consultancy services as a member of the steering committee for the MSM campaign. £ 102.50 Berliner Aids-Hilfe e.V. Expenses related to provision of consultancy services as a member of the steering committee for the MSM campaign. £ 489.10 Croatian association for HIV and viral hepatitis Grant funding to support the Closing Gaps in HIV Continuum of Care program to individualise medical education on the continuum of HIV and HCV care in healthcare systems (health and auxiliary professions) by implementing an online education portal and organising regional seminars for knowledge adoption to attain better patient outcomes. 366,782 Kuna CSD Deutschland e.V Fees and related expenses for provision of consultancy services as a member of the steering committee for the MSM campaign. £ 1,322.23 European Cancer Patients Coalition Fees and related expenses for provision of consultancy services as part of the “Meeting of Minds” project. £ 927.97 European Liver Patients’ Association (ELPA) Grant funding to support ELPA’s 2016 community scientific meeting to address key science and policy issues related to liver diseases. € 16,000.00 European Liver Patients’ Association (ELPA) Grant funding to support the organisation’s initiatives to address approaches to diagnosis, screening and new cures available for viral hepatitis and liver diseases in Europe while increasing awareness of liver disease and tackling stigma. € 26,7500.00 European Liver Patients’ Association (ELPA) Grant funding to support the HepCORE project, which aims to establish a baseline measurement of how countries are doing on combatting viral hepatitis by understanding where they are successful, where gaps remain, by comparing national country data to show progress, develop a tool to influence policy makers at EU or national level and exchange best practice. € 75,000.00 European Liver Patients’ Association (ELPA) Grant funding to support ELPA’s 2017 community scientific meeting to address key science and policy issues related to liver diseases € 16,000.00 European Liver Patients’ Association (ELPA) Expenses related to the provision of consultancy services as part of the “Meeting of Minds” project. £ 523.46 EUROPEAN PATIENTS’ FORUM Grant funding to support EPF’s Capacity Building Programme which supports patient organisations to strengthen their role as equal players in the healthcare environment. € 30,000.00 Foundation De Regenboog Group Grant funding to support the Correlation Network to conduct HCV capacity building trainings in European PWID organisations/harm reduction programs ahead of European Testing Week 2017. The project aimed to increase knowledge and skills among staff and peers, to teach HCV testing and behaviour interventions to minimise risk behaviours and to facilitate testing and linkage-to-care. € 27,000.00 GAT Portugal Fees for provision of consultancy services at multidisciplinary advisory board. € 900.00 Hepactive association Grant funding to support Bulgarian patients eligible for DAA treatment with access to PCR RNA test (polymerase chain reaction for viral load) without hospitalisation. € 73,360.00 Hepatitis Aid Austria Fees and related expenses for provision of consultancy services for the ELPA University Project. £ 574.00 HIV i-Base Grant funding to support HIV i-Base’s general costs for information services, including direct services to HIV positive people through the online and email-based treatment information service, their website, and the Q&A service. £ 69,000.00 HIV Norge Fees and related expenses for provision of consultancy services as a member of the steering committee for the MSM campaign. £ 897.08 HULOH Hepatos – Podružnica Zagreb Expenses related to the provision of consultancy services for the ELPA University Project. £ 626.19 International Diabetes Federation Europe Fees and related expenses for provision of consultancy services as part of the “Meeting of Minds” project £ 1,285.97 International Network on Hepatitis in Substance Users (INHSU) Grant funding to support the development and implementation of an international education program for healthcare practitioners in drug and alcohol clinics, to support increased hepatitis C screening, linkage-to-care and treatment among PWID. € 305,995.00 International Osteoporosis Foundation Expenses related to the provision of consultancy services as part of the “Meeting of Minds” project. £ 496.01 JUSTRI Grant funding to support JUSTRI’s ‘Coming of Age’ guide and its translation into French, Italian, Portuguese and Spanish, as well as test its acceptability by structured evaluation. £ 20,699.00 JUSTRI Grant funding to support JUSTRI’s HBV project to create and assess a practical resource for patients living with HBV to better understand and be more engaged in the monitoring of their hepatitis B infection, facilitating engagement in care and improving patient safety and satisfaction. £ 19,918.00 JUSTRI Grant funding to support JUSTRI’s toolkit training which provides a one-day teaching programme to individuals in the UK and SEE countries who wish to develop skills in research and presentation techniques. The course provides practical skills and enhances areas of opportunity such as training and /or exchanges between units as well as capacity building for the participants. £ 12,433.00 JUSTRI Grant funding to support JUSTRI to plan, produce and execute two medical student trainings on HIV, viral hepatitis, TB and sexual health in two different medical school settings in Romania and Turkey. £ 17,651.00 JUSTRI Grant funding to support JUSTRI’s nurse training programme, which aims to produce and deliver a teaching course to educate nurses about HIV, viral hepatitis, TB and sexual health testing to improve their knowledge base, reduce stigma, improve communication skills and improve knowledge of HIV and associated conditions. £ 25,932.00 JUSTRI Grant funding to support JUSTRI to provide teaching on a range of HIV related issues to non-HIV trained obstetricians and gynaecologists in order to support those who provide services in this field and allow them to disseminate their knowledge to other health care professionals in their own settings. £ 20,737.00 JUSTRI Grant funding to support JUSTRISLIDE, a global, online, slide library of presentations relating to HIV, viral hepatitis, tuberculosis and nursing. £ 15,172.00 JUSTRI Grant funding to support a bilateral skills exchange between UK based healthcare professionals, working with HIV, viral hepatitis and tuberculosis, with those based in the countries of SEE to improve clinical skills and knowledge. £ 18,804.00 JUSTRI Grant funding to support for the planning and execution of two one-day trainings providing practical skills in non-invasive liver assessment techniques to HCPs working in viral hepatitis. £ 20,531.00 NAM Aidsmap Fees for provision of consultancy services at multidisciplinary advisory board. £ 900.00 NAM Publications Grant funding to support the publication of high quality, independent and multilingual news services from two of the most important HIV scientific meetings of the year on www.aidsmap.com. £ 20,000.00 NAM Publications Fees for the provision of consultancy services as part of the “Meeting of Minds” project. £ 350.00 Patient Advocacy Alliance Grant funding to support a project to identify the unmet needs of young people, the barriers to their engagement at local, regional and international level and to identify good practice to ensure young people are involved in scientific and policy decisions in the global response to the HIV epidemic. £ 14,300.00 Patient Advocacy Alliance Expenses related to the provision of consultancy services as part of the “Meeting of Minds” project. £ 342.50 Plus Onlus Fees and related expenses for provision of consultancy services as a member of the steering committee for the MSM campaign. £ 1,471.90 Positive Voice Expenses related to the provision of consultancy services at an IAS Community meeting. £ 376.00 Projecte dels NOMS-Hispanosida Grant funding to support PDN’s community awareness initiative “We’ll make Barcelona a city without AIDS. Do the HIBV test!” in European HIV-Hepatitis Testing Week 2017. This was a community initiative to create awareness and action within the local community. € 8,000.00 Projecte dels NOMS-Hispanosida Fees for provision of consultancy services at multidisciplinary advisory board. £ 2,160.00 Riksförenigen Hepatitis C The National Union of Hepatitis C Fees and related expenses for provision of consultancy services for the ELPA University Project. € 1,321.86 SIDC Lebanon Grant funding to support a project to better educate the general public, university and school students about HIV and STIs to avoid misconceptions and discrimination against HIV and LGBQI. $ 89,742.05 SOS Hepatitis Expenses related to the provision of consultancy services for the ELPA University Project. £ 368.30 Stichting Positive Women of the World Grant funding to support a programme to address the issues that migrant women living with HIV/AIDS and their families face in the Netherlands in relation to healthcare and treatment, stigma and social inclusion. € 3,750.00 The European AIDS Treatment Group Grant funding to support a project to increase patient and healthcare provider knowledge and awareness of the medical and psychosocial aspects of young people living with HIV and how they can make informed decisions as they get older. € 79,700.00 The European AIDS Treatment Group Grant funding to support the STEP-UP training programme, which provides HIV education and personal development training to people who have an aspiration to become the future generation of HIV ambassadors and leaders within the sector across Europe and Central Asia. € 150,000.00 The European AIDS Treatment Group Grant funding to support EATG’s core activities € 185,000.00 The European AIDS Treatment Group Grant funding to support EATG’s 2017 community scientific meetings to address the HIV/HCV community’s need for information to increase community awareness. € 90,000.00 The European AIDS Treatment Group Grant funding to support the Ageing with HIV Project, which aims at better understanding the current needs of PLWHIV/AIDS at different life age stages, and to identify advocacy priorities in the HIV and ageing domain. This phase of the project focusses on the unmet clinical and psychosocial needs of people who are 18-45 years (living with HIV for at least 10 years). € 79,700.00 The European AIDS Treatment Group Grant funding to support EATG’s 2016 community scientific meetings to address the HIV/HCV community’s urgent need for information to increase community awareness. € 19,000.00 The Finnish Kidney and Liver Association Fees and related expenses for provision of consultancy services for the ELPA University Project. £ 2,065.35 The NAZ Project (London) Grant funding to support NAZ’s film called ‘Faces’, targeting young black Africans in the UK to improve knowledge around HIV and encourage HIV testing in this group. Funding also supports events in the UK and two sub-Saharan countries to promote the film, a social media campaign and an online toolkit providing information that is tailored and relevant to local audiences in the countries the film is screened. £ 67,000.00 United against Hepatitis Expenses related to the provision of consultancy services for the ELPA University Project. £ 1,343.70
Source: www.gilead.com
Подробнее
Видео отзывы
Лекарства от гепатита C
Комбинации препаратов в зависимости от генотипа вируса
Наименование Страна Производитель Цена за 1 уп. Цена за курс Для каких генотипов
Софосбувир + Велпатасвир
Velpanat ХИТ ПРОДАЖ! Индия Natco узнать цену узнать цену все
Velasof ХИТ ПРОДАЖ! Индия Hetero узнать цену узнать цену все
Lucisovel Шри-Ланка Lucius узнать цену узнать цену все
SofoVel ХИТ ПРОДАЖ! Пакистан AVA Pharmaceuticals (Pvt) Ltd узнать цену узнать цену все
Софосбувир и Даклатасвир
Hepcinat и Natdac ХИТ ПРОДАЖ! Индия Natco узнать цену узнать цену 1, 2, 3
Sofovir и Daclahep Индия Hetero узнать цену узнать цену 1, 2, 3
Sovihep и Dacihep Индия Zydus узнать цену узнать цену 1, 2, 3
Lucisof и Lucidac Шри-Ланка Lucius узнать цену узнать цену 1, 2, 3
SofoDac ХИТ ПРОДАЖ! Пакистан AVA Pharmaceuticals (Pvt) Ltd узнать цену узнать цену 1, 2, 3
Софосбувир + Ледипасвир
Hepcinat LP Индия Natco узнать цену узнать цену 1, 4
Ledifos Индия Hetero узнать цену узнать цену 1, 4
Ledihep Индия Zydus узнать цену узнать цену 1, 4
Lucisole Шри-Ланка Lucius узнать цену узнать цену 1, 4
500
миллионов
человек являются носителями
вируса гепатита С
по данным Всемирной Организации Здоровья
5%
ГРАЖДАН В РФ
являются носителями
вируса гепатита С
98%
НАШИХ КЛИЕНТОВ
получают "минус" через 14 дней
после начала приема лекарств
по результатам количественного анализа
Почему надежнее приобрести лекарства именно у нас?

1.Доставка по Москве: 2-3 часа

Мы несем ответственность за успех вашей терапии. Если у вас закончились таблетки - мы доставим новую упаковку без промедления, и вам не придется прерывать терапию.

2.Стоимость без наценок и скрытых платежей

Мы не выставляем на сайте заниженные цены ради привлечения клиентов. У нас нет дополнительной оплаты за доставку и тому подобных хитростей. Цена, указанная на сайте неизменна.

3.Препараты действительно излечивают от Гепатита С

Да, у нас не самый большой ассортимент. Но за качество и эффективность каждого препарата, представленного у нас, мы ручаемся головой. Мы не размещаем отзывы, написанные под копирку. Вы всегда можете попросить у нас контакты наших бывших клиентов (тех, кто не против этого) практически из любого города РФ или СНГ - никакие актеры не смогут передать эмоции вылечившихся людей. По разговору вы это поймете.

Доставка софосбувира
Как происходит доставка более подробно:
Как происходит доставка:
  • Сертифицированная курьерская служба доставит препараты Вам на дом (время доставки согласовывается)
  • Сроки доставки по Москве 2-3 рабочих дня
  • Стоимость Доставки 3% от Суммы заказа. Дорого? Позвоните сделаем скидку.
  • Перед оплатой можно проверить препараты (голограмы, дата выпуска, стоимость в рупиях)
  • Во вложениях диеты, аннотации на русском языке, сертификаты. Ссылки на масс. лабораторные исследования и сертификаты дистрибьюторов мы отправляем онлайн еще до заказа.
  • Оплата наличными
Самое главное - гарантия излечения
Заказать доставку И избавиться от гепатита С навсегда
Статистика развития гепатита С
  • Интерфероновые схемы лечения излечивали всего до 35-40% пациентов
  • Частота рецидивов после интерфероновой терапии составляет ~ 20%
  • Софосбувир в комбинации с даклатасвиром, ледипасвиром или велпатасвиром излечивает 98% пациентов
  • При правильно подобранной комбинации и сроке терапии рецидивов нет!
Вылечить Гепатит C
Мы предлагаем: эффективные лицензированные препараты из Индии
Официально гарантируем 100% излечение
Лабораторная экспертиза
Оригинальность
Независимая лабораторная экспертиза. Hepcinat (sofosbuvir)
Независимая лабораторная экспертиза. Natdac (daclatasvir).jpg
Независимая лабораторная экспертиза. Hepcinat LP (sofosbuvir + ledipasvir)
Независимая лабораторная экспертиза. Ledifos (sofosbuvir + ledipasvir)
Наши сертификаты
Доставляем во все регионы РФ,
страны СНГ и страны Евросоюза
Часто задаваемые вопросы
Где гарантия что я вылечусь от гепатита С?
У меня очень малый вес, что делать?
Можно ли принимать препараты детям?
Сколько стоит и сколько времени занимает доставка по Москве?
Я проездом в Москве, можно ли получить лекарство на вокзале/аэропорту?
Сколько времени занимает доставка по России?
Нужна ли предоплата?
Какие способы оплаты возможны?
По какому курсу валют происходит расчет?
Оставьте заявку и мы свяжемся с Вами

Мы не передаем Вашу персональную информацию третьим лицам.

Оставьте заявку и мы свяжемся с Вами

Мы не передаем Вашу персональную информацию третьим лицам.

Оставьте заявку и мы свяжемся с Вами

Мы не передаем Вашу персональную информацию третьим лицам.

Оставьте заявку и мы свяжемся с Вами

Мы не передаем Вашу персональную информацию третьим лицам.